Myeloperoxidase is a key regulator of oxidative stress-mediated apoptosis in myeloid leukemic cells

Clinical Cancer Research

Volumn 13, Issue 18, 2007, Pages 5436-5445

  Nakazato, Tomonori ^a   Sagawa, Morihiko ^a   Yamato, Kenji ^b   Xian, Mingji ^a   Yamamoto, Takehiro ^a   Suematsu, Makoto ^a   Ikeda, Yasuo ^a   Kizaki, Masahiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; EPIGALLOCATECHIN GALLATE; FLUORESCEIN; HYPOCHLOROUS ACID; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SUCCINYLACETONE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LEUKEMIA CELL; MYELOID LEUKEMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANILINE COMPOUNDS; ANTIOXIDANTS; APOPTOSIS; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; HEME; HUMANS; LEUKEMIA, MYELOID, ACUTE; OXIDATIVE STRESS; PEROXIDASE; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 34848852035     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0481     Document Type: Article

References (47)

1. Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005;106:1154-63.
2. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92:3007-17.
3. Takubo T, Kubota Y, Oguma S, et al. Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response. Blood Cells 1983;9:501-14.
4. Matsuo T, Cox C, Bennett JM. Prognostic significance of myeloperoxidase positivity of blast cells in acute myeloblastic leukemia without maturation (FAB:M1): an ECOG study. Hematol Pathol 1989;3:153-8.
5. Suic M, Boban D, Markovic-Glamocak M, Petrovecki M, Marusic M, Labar B. Prognostic significance of cytochemical analysis of leukemic M2 blasts. Med Oncol Tumor Pharmacother 1992;9:41-5.
6. Kuriyama K, Tomonaga M, Kobayashi T, et al. Morphological diagnosis of the Japan adult leukemia study group acute myeloid leukemia protocols: central review. Int J Hematol 2001;73:93-9.
7. Matsuo T, Kuriyama K, Miyazaki Y, et al. The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acutemyeloid leukemia, even in the patients with normal karyotype. Leukemia 2003;17:1538 -43.
8. Nakazato T, Ito K, Miyakawa Y, et al. Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo. Haematologica 2005;90:317-25.
9. Kizaki M, Matsushita H, Takayama N, et al. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood 1996;88:1824-33.
10. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991;77:1080-6.
11. Fiskus W, Pranpat M, Balasis M, et al. Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemic cells. Clin Cancer Res 2006;12:5869-77.
12. Shin K, Hasegawa H, Lonnerdel B. Mutations affecting the calcium-binding site of myeloperoxidase and lactoperoxidase. Biochem Biophys Res Commun 2001;281:1024-9.
13. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 2002;278:3170-5.
14. Kettle AJ, Gedye CA, Winterbourn CC. Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem J 1997;321:503-8.
15. Castaneda VL, Parmley RT, Pinnix IB, Raju SG, Guzman GS, Kinkade JM, Jr. Ultrastructural, immunochemical, and cytochemical study of myeloperoxidase in myeloid leukemia HL-60 cells following treatment with succinylacetone, an inhibitor of heme biosynthesis. Exp Hematol 1992;20:916-24.
16. Nauseef WM, McCormick S, Yi H. Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase. Blood 1992;80:2622-33.
17. PinniX IB, Guzman GS, Bonkovsky HL, Zaki SR, Kinkade JM, Jr. The post-translational processing of myeloperoxidase is regulated by the availability of heme. Arch Biochem Biophys 1994;312:447-58.
18. Zhu B-Z, Antholine WA, Frei B. Thiourea protects against copper-induced oxidative damage by formation of a redox-inactive thiourea-copper complex. Free Radic Biol Med 2002;32:1333-8.
19. Jing Y, Dai J, Chalmens-Redman RME, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999;94:2102-11.
20. Dai J, Weinberg RS, Waxman S, Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999;93:268-77.
21. Carmosino I, Latagliata R, Avvisati G, et al. Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia. Haematologica 2004;89:615-7.
22. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001;11:173-86.
23. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 2003;15:247-54.
24. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood 2001;98:2603-14.
25. Bigelow DC, Squier TC. Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins. Biochem Biophys Acta 2005;1703:121-34.
26. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunology Today 1994;15:7-10.
27. Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci 1996;21:83-6.
28. Clutton S. The importance of oxidative stress in apoptosis. Br Med Bull 1997;53:662-8.
29. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redox control of cell death. Antioxid Redox Signal 2002;4:405-14.
30. Tobiume K, Matsuzawa A, Takahashi T, et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001;2:222-8.
31. Lea MA, Xiao Q, Sadhukhan AK, Cottle S, Wang ZY, Yang CS. Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett 1996;68:231-6.
32. Islam S, Islam N, Kermode T, et al. Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 2000;270:793-7.
33. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997;89:1881-6.
34. Bertolini F, Fusetti L, Cinieri S, Martinelli G, Pruneri G. Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Leukemia 2000;14:1477-82.
35. Pisters AMW, Newman RA, Coldman B, et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol 2001;19:1830-8.
36. Sergediene E, Jo« nsson K, Szymusiak H, Tyrakowska B, Rietjens IMCM, Cenas N. Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationship. FEBS Lett 1999;462:392-6.
37. Nakagawa H, Hasumi K, Woo JT, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis 2004;25:1567-74.
38. Bruno JG, Herman TS, Cano VL, Stribling L, Kiel JL. Selective cytotoxicity of 3-amino-L-tyrosine correlates with peroxidase activity. In Vito Cell Biol Anim 1999;35:376-82.
39. 2-induced apoptosis of HL60 human leukemia cells. J Biol Chem 2000;275:22461-9.
40. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999;26:463-71.
41. Ren JG, Xia HL, Just T, Dai YR. Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation. FEBS Lett 2001;19:123-32.
42. Bilski P, Belanger AG, Chignell CF. Photosensitized oxidation of 2′,7′-dichlorofluorescin: singlet oxygen does not contribute to the formation of fluorescent oxidation product 2′,7′- dichlorofluorescein. Free Radic Biol Med 2002;33:938-46.
43. Hileman EO, Liu J, Albitar M, Keating MJ, Huang P. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol 2004;53:209-19.
44. Mansat-de Mas V, Bezombes C, Quillet-Mary A, et al. Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol Pharmacol 1999;56:867-74.
45. Panaretakis T, Pokrovskaja K, Shoshan MC, Grander D. Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J Biol Chem 2002;277:44317-26.
46. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000;407:390-5.
47. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of acute leukemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-8.